Revisiting Glycogen in Cancer: A Conspicuous and Targetable Enabler of Malignant Transformation

by Tashbib Khan, Mitchell A. Sullivan, Jennifer H. Gunter, Thomas Kryza, Nicholas Lyons, Yaowu He, John D. Hooper
Published 2020-10-01

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer

by Tahleesa J. Cuda, Yaowu He, Thomas Kryza, Tashbib Khan, Brian W. Tse, Kamil A. Sokolowski, Cheng Liu, Nicholas Lyons, Madeline Gough, Cameron E. Snell, David K. Wyld, Stephen Rose, Andrew D. Riddell, Andrew R. L. Stevenson, Paul A. Thomas, David A. Clark, Simon Puttick, John D. Hooper
Published 2021-01-01

Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer

by Katherine B. Sahin, Esha T. Shah, Genevieve P. Ferguson, Christopher Molloy, Priyakshi Kalita-de Croft, Sarah A. Hayes, Amanda Hudson, Emily Colvin, Hannah Kamitakahara, Rozelle Harvie, Csilla Hasovits, Tashbib Khan, Pascal H. G. Duijf, Viive M. Howell, Yaowu He, Emma Bolderson, John D. Hooper, Sunil R. Lakhani, Derek J. Richard, Kenneth J. O’Byrne, Mark N. Adams
Published 2021-09-01

Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma

by Tashbib Khan, Yaowu He, Thomas Kryza, Brittney S. Harrington, Jennifer H. Gunter, Mitchell A. Sullivan, Tahleesa Cuda, Rebecca Rogers, Claire M. Davies, Amy Broomfield, Madeline Gough, Andy C. Wu, Thomas McGann, S. John Weroha, Paul Haluska, Josephine M. Forbes, Jane E. Armes, Sinead C. Barry, Jermaine I. Coward, Nisha Jagasia, Naven Chetty, Cameron E. Snell, Rohan Lourie, Lewis C. Perrin, John D. Hooper
Published 2020-04-01